SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 27 filers reported holding SPRING BK PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $67,000 | +3.1% | 49,933 | +12.9% | 0.00% | – |
| Q2 2020 | $65,000 | +75.7% | 44,225 | +12.1% | 0.00% | – |
| Q1 2020 | $37,000 | -41.3% | 39,463 | 0.0% | 0.00% | – |
| Q4 2019 | $63,000 | -54.3% | 39,463 | -1.5% | 0.00% | – |
| Q3 2019 | $138,000 | -80.0% | 40,081 | -78.6% | 0.00% | – |
| Q2 2019 | $690,000 | -64.3% | 186,901 | +1.5% | 0.00% | – |
| Q1 2019 | $1,931,000 | +8.2% | 184,064 | +7.2% | 0.00% | -100.0% |
| Q4 2018 | $1,785,000 | -13.0% | 171,750 | +0.9% | 0.00% | 0.0% |
| Q3 2018 | $2,051,000 | +355.8% | 170,243 | +349.0% | 0.00% | – |
| Q2 2018 | $450,000 | +56.2% | 37,915 | +103.1% | 0.00% | – |
| Q1 2018 | $288,000 | +37.8% | 18,669 | +20.3% | 0.00% | – |
| Q4 2017 | $209,000 | +2.0% | 15,518 | +27.4% | 0.00% | – |
| Q3 2017 | $205,000 | – | 12,184 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 785,950 | $9,314,000 | 0.91% |
| Morse Asset Management, Inc | 177,500 | $2,103,000 | 0.58% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 281,213 | $3,332,000 | 0.38% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 73,000 | $860,000 | 0.33% |
| TIEDEMANN ADVISORS, LLC | 412,049 | $4,883,000 | 0.31% |
| Private Capital Advisors, Inc. | 52,335 | $620,000 | 0.19% |
| SECTORAL ASSET MANAGEMENT INC | 131,656 | $1,560,000 | 0.17% |
| Lee Financial Co | 18,750 | $222,000 | 0.05% |
| Baker Brothers Advisors | 373,144 | $4,422,000 | 0.03% |
| Alyeska Investment Group, L.P. | 200,000 | $2,370,000 | 0.02% |